Home >> Mini Reviews in Medicinal Chemistry, Volume 3, Number 3
Mini Reviews in Medicinal Chemistry logo Bentham Science Publishers logo

The aim of Mini-Reviews in Medicinal Chemistry is to publish short reviews on the important recent developments in medicinal chemistry and allied disciplines.

The scope of Mini-Reviews in Medicinal Chemistry will cover all areas of medicinal chemistry including developments in rational drug design, synthetic chemistry, bioorganic chemistry, high-throughput screening, combinatorial chemistry, drug targets, and natural product research and structure-activity relationship studies.

Mini-Reviews in Medicinal Chemistry is an essential journal for every medicinal and pharmaceutical chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Publisher: Bentham Science Publishers

Related content
Volume 3, Number 3, May 2003

< previous issue | all issues | next issue >

Review article

Peptide Derivatives as Agonists or Antagonists of Formylpeptide Receptors: Analysis of their Effects on Neutrophils
pp. 167-173(7)
Authors: Dalpiaz A.; Scatturin A.

Biological Role of Formaldehyde, and Cycles Related to Methylation, Demethylation, and Formaldehyde Production
pp. 175-192(18)
Author: Kalasz H.

Vitamin D Receptor as a Drug Discovery Target
pp. 193-204(12)
Authors: Pinette K.V.; Yee Y.K.; Amegadzie B.Y.; Nagpal S.

New Aspects of Cyclosporin A Mode of Action: from Gene Silencing to Gene Up-Regulation
pp. 205-214(10)
Authors: Mascarell L.; Truffa-Bachi P.

The 1,4-Dihydropyridine Nucleus: A Pharmacophoric Template Part 1. Actions at Ion Channels
pp. 215-223(9)
Author: Triggle D.J.

Steroid 5agr-Reductase Inhibitors
pp. 225-237(13)
Authors: Flores E.; Bratoeff E.; Cabeza M.; Ramirez E.; Quiroz A.; Heuze I.

Current Strategies for the Development of Novel Antipsychotic Drugs
pp. 239-251(14)
Author: Bolos J.

Biological Properties and Therapeutic Potential of Bilirubin
pp. 253-256(4)
Authors: McGeary R.P.; Szyczew A.J.; Toth I.

The p53-Mdm2 Pathway: Targets for the Development of New Anticancer Therapeutics
pp. 257-270(14)
Authors: Zheleva D.I.; Lane D.P.; Fischer P.M.

< previous issue | all issues | next issue >

Marked list

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
^ Back to top
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page